INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. – ORGO

NEW YORK CITY, NY / ACCESS Newswire / November 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc.("Organogenesis" or the "Company") (NASDAQ:ORGO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Organogenesis and certain of its officers and/or directors […]

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fluor Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLR

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fluor Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLR GlobeNewswire November 02, 2025 NEW YORK, Nov. 02, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fluor Corporation (NYSE: FLR) between February 18, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BAX

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BAX GlobeNewswire November 02, 2025 NEW YORK, Nov. 02, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Baxter International Inc. (NYSE: BAX) between

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATYR

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATYR GlobeNewswire November 02, 2025 NEW YORK, Nov. 02, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR)

Belite Bio Announces UK’s Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant

Belite Bio Announces UK's Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant GlobeNewswire November 02, 2025 MHRA response is based on the Phase 3 DRAGON interim analysis results Topline final data expected in Q4 2025 SAN DIEGO, Nov.

Buck Sexton Warns: “America’s Next Wealth Boom Has Already Begun”

Buck Sexton Warns: “America's Next Wealth Boom Has Already Begun” Exclusive Interview Reveals How an estimated $2.2 Trillion “Manhattan II” Initiative Could Create a New Generation of Millionaires While Rebuilding the U.S. Economy From the Ground Up GlobeNewswire November 02, 2025 Washington, D.C., Nov. 02, 2025 (GLOBE NEWSWIRE) — Former CIA officer and national security

Mutuum Finance (MUTM) Progresses Through Roadmap Phase 2 as It Attracts Over 17,600 Participants

Mutuum Finance (MUTM) Progresses Through Roadmap Phase 2 as It Attracts Over 17,600 Participants GlobeNewswire November 02, 2025 Dubai, UAE, Nov. 02, 2025 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM) continues to advance steadily through its development roadmap, completing its Phase 2 milestones as the project moves closer to the V1 protocol launch planned for Q4

Sofucor Launches Black Friday Sale: Save Big on Aura, Wave, and Neo Fans

Sofucor Launches Black Friday Sale: Save Big on Aura, Wave, and Neo Fans GlobeNewswire November 02, 2025 HOUSTON, Nov. 02, 2025 (GLOBE NEWSWIRE) — U.S. ceiling fan brand Sofucor today announced the official start of its nationwide Black Friday Sale, offering major savings on its most popular ceiling fan collections–Aura, Wave, and Neo–through November 30

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire November 02, 2025 NEW YORK, Nov. 02, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims

AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire November 02, 2025 NEW YORK, Nov. 02, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on

Scroll to Top